TrialBlood advances2026
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma.
Keri Toner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialBlood advances2026
Keri Toner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.